NASDAQ:SCPH - Scpharmaceuticals Stock Price, Forecast & News

Scpharmaceuticals' stock was trading at $7.77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SCPH stock has decreased by 8.2% and is now trading at $7.13. View which stocks have been mosted impacted by Coronavirus.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scpharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Scpharmaceuticals.

Scpharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Scpharmaceuticals.

Scpharmaceuticals Inc (NASDAQ:SCPH) posted its earnings results on Tuesday, March, 24th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.52) by $0.06. View Scpharmaceuticals' earnings history.

1 brokerages have issued 1-year target prices for Scpharmaceuticals' shares. Their forecasts range from $13.00 to $13.00. On average, they expect Scpharmaceuticals' share price to reach $13.00 in the next year. This suggests a possible upside of 82.3% from the stock's current price. View analysts' price targets for Scpharmaceuticals.

News headlines about SCPH stock have been trending neutral on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Scpharmaceuticals earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutScpharmaceuticals.

Scpharmaceuticals saw a increase in short interest in March. As of March 13th, there was short interest totaling 6,500 shares, an increase of 58.5% from the February 27th total of 4,100 shares. Based on an average trading volume of 78,300 shares, the short-interest ratio is currently 0.1 days. Approximately 0.1% of the company's shares are sold short. View Scpharmaceuticals' Current Options Chain.

Some companies that are related to Scpharmaceuticals include Kadmon (KDMN), Eagle Pharmaceuticals (EGRX), Retrophin (RTRX), Arcus Biosciences (RCUS), Radius Health (RDUS), Athenex (ATNX), Cara Therapeutics (CARA), Molecular Templates (MTEM), ImmunoGen (IMGN), Portola Pharmaceuticals (PTLA), Vanda Pharmaceuticals (VNDA), Nabriva Therapeutics (NBRV), Collegium Pharmaceutical (COLL), Akero Therapeutics (AKRO) and ZIOPHARM Oncology (ZIOP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Scpharmaceuticals investors own include Adamas Pharmaceuticals (ADMS), Crispr Therapeutics (CRSP), Melinta Therapeutics (MLNT), Selecta Biosciences (SELB), Protalix Biotherapeutics (PLX), Fate Therapeutics (FATE), Progenics Pharmaceuticals (PGNX), Agile Therapeutics (AGRX), Clearside Biomedical (CLSD) and Catalyst Pharmaceuticals (CPRX).

(SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SCPH stock can currently be purchased for approximately $7.13.

Scpharmaceuticals has a market capitalization of $149.60 million. The company earns $-33,000,000.00 in net income (profit) each year or ($1.77) on an earnings per share basis. Scpharmaceuticals employs 21 workers across the globe. View additional information about Scpharmaceuticals.

The official website for Scpharmaceuticals is http://www.scpharma.com/.

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected]